A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03431350 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03431350
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-02
- Primary completion
- 2021-08-31
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.